Argenx Nv Adr Stock Alpha and Beta Analysis

ARGX Stock  USD 614.59  7.43  1.22%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as argenx NV ADR. It also helps investors analyze the systematic and unsystematic risks associated with investing in Argenx NV over a specified time horizon. Remember, high Argenx NV's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Argenx NV's market risk premium analysis include:
Beta
(0.14)
Alpha
0.29
Risk
2.01
Sharpe Ratio
0.15
Expected Return
0.3
Please note that although Argenx NV alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Argenx NV did 0.29  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of argenx NV ADR stock's relative risk over its benchmark. argenx NV ADR has a beta of 0.14  . As returns on the market increase, returns on owning Argenx NV are expected to decrease at a much lower rate. During the bear market, Argenx NV is likely to outperform the market. At this time, Argenx NV's Book Value Per Share is fairly stable compared to the past year. Tangible Asset Value is likely to rise to about 581.7 M in 2024, whereas Net Current Asset Value is likely to drop slightly above 19.5 M in 2024.

Enterprise Value

20.71 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Argenx NV Backtesting, Argenx NV Valuation, Argenx NV Correlation, Argenx NV Hype Analysis, Argenx NV Volatility, Argenx NV History and analyze Argenx NV Performance.

Argenx NV Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Argenx NV market risk premium is the additional return an investor will receive from holding Argenx NV long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Argenx NV. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Argenx NV's performance over market.
α0.29   β-0.14

Argenx NV expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Argenx NV's Buy-and-hold return. Our buy-and-hold chart shows how Argenx NV performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Argenx NV Market Price Analysis

Market price analysis indicators help investors to evaluate how Argenx NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Argenx NV shares will generate the highest return on investment. By understating and applying Argenx NV stock market price indicators, traders can identify Argenx NV position entry and exit signals to maximize returns.

Argenx NV Return and Market Media

The median price of Argenx NV for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 548.49 with a coefficient of variation of 5.16. The daily time series for the period is distributed with a sample standard deviation of 28.65, arithmetic mean of 554.72, and mean deviation of 24.12. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Heres Why You Should Hold Argenx SE
10/31/2024
2
argenx Issues Earnings Results
11/01/2024
3
Is Argenx Outperforming Other Medical Stocks This Year
11/05/2024
4
Artisan Partners Limited Partnership Bolsters Stake in iRhythm Technologies Inc
11/13/2024
5
Deep Track Capital, LP Acquires New Stake in Silence Therapeutics PLC
11/14/2024
6
Paradigm Biocapital Advisors LP Increases Stake in Tarsus Pharmaceuticals Inc
11/15/2024
7
Is argenx SE the Best Immunotherapy Stock to Buy Now
11/18/2024
8
Can Argenx stock sustain its autoimmune category dominance Oppenheimer weighs in
11/21/2024
9
Cynosure Group LLC Sells 499 Shares of argenx SE
11/27/2024

About Argenx NV Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Argenx or other stocks. Alpha measures the amount that position in argenx NV ADR has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding24.01246.39148.6109.24
PTB Ratio7.067.325.317.68

Argenx NV Upcoming Company Events

As portrayed in its financial statements, the presentation of Argenx NV's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Argenx NV's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Argenx NV's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Argenx NV. Please utilize our Beneish M Score to check the likelihood of Argenx NV's management manipulating its earnings.
7th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Argenx NV

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Argenx Stock Analysis

When running Argenx NV's price analysis, check to measure Argenx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argenx NV is operating at the current time. Most of Argenx NV's value examination focuses on studying past and present price action to predict the probability of Argenx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argenx NV's price. Additionally, you may evaluate how the addition of Argenx NV to your portfolios can decrease your overall portfolio volatility.